![Paul Schaffer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Schaffer currently works at Telix Pharmaceuticals Ltd., as Chief Technology Officer from 2025.
Dr. Schaffer also formerly worked at Centre For Probe Development & Commercialization, as Director from 2018 to 2021 and ARTMS, Inc., as Chief Technology Officer from 2018 to 2025.
| Unternehmen | Position | Beginn |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 07.04.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | 28.03.2018 |
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Direktor/Vorstandsmitglied | 17.06.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
